Pfizer Inc (PFE)

pos +0.00
Today's Range: 0.00 - 0.00 | PFE Avg Daily Volume: 24,690,400
Last Update: 12/05/16 - 4:02 PM EST
Volume: 0
YTD Performance: -2.14%
Open: $0.00
Previous Close: $31.59
52 Week Range: $28.25 - $37.39
Oustanding Shares: 6,068,355,132
Market Cap: 191,942,072,825
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 7 7 7
Moderate Buy 0 0 0 0
Hold 8 9 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.13 1.92 1.92
Latest Dividend: 0.30
Latest Dividend Yield: 3.79%
Dividend Ex-Date: 11/08/16
Price Earnings Ratio: 15.13
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
15.13 31.30 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-9.15% -3.69% 1.09%
Revenue -1.50 -0.20 -0.06
Net Income -23.80 -0.30 -0.10
EPS -21.70 -0.40 -0.17
Earnings for PFE:
Revenue 48.85B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $0.50 $0.62 $2.41 $2.60
Number of Analysts 8 2 8 11
High Estimate $0.54 $0.64 $2.43 $2.67
Low Estimate $0.47 $0.60 $2.38 $2.45
Prior Year $0.53 $0.67 $2.20 $2.41
Growth Rate (Year over Year) -5.42% -7.46% 9.55% 7.70%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Market should still be able to breathe once central-bank prop is removed.
A new period of accumulation and sideways price action is likely needed before any upside movess.
Nov 29, 2016 | 7:47 AM EST
PFE was upgraded from Equal-weight to Overweight, Barclays said. $38 price target. Company should be able to use foreign cash to boost ...
Small-caps could also benefit from abating tax-loss selling.
Firms' 13F filings show how they've followed in the footsteps of the father of value investing.
As we all know, the stock market and the economy abhor uncertainty.
But don't buy blindly. There are too many companies that can be retaliated against.
Stocks in the health care sector seem to have no underpinnings whatsoever.
And if it's lost, good luck getting it back.

Columnist Conversations

BC is moving well today.  Shares are up over 3.5% on fairly heavy trade and are trading at new 2016 highs...
Markets taking the latest rejection of the status quo in Italy in stride as the reforms were expected to lose ...
Merck continues to retreat from November's failed breakout.  Back on 9th and 10th of last month the stock...
Trifecta Stocks name Disney is bumping up to the 100 area hereon some good turnover and bullish flow today (an...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.